CSE bulletin 2026-0904
The Class B subordinate voting shares of Quantum Biopharma Ltd. will be delisted from the Canadian Securities Exchange at the market close on Sept. 4, 2026.
The issuer will continue to trade on the Nasdaq Stock Market.
Date: market close, Sept. 4, 2026
Symbol: QNTM
© 2026 Canjex Publishing Ltd. All rights reserved.